A study from the University of Virginia’s Department of Biomedical Engineering has identified a critical mechanism driving fibrosis, or scarring, in response to medical implants made with biomaterial hydrogels.
With the rise in incidence of food allergies in children in the past decade, there has been a corresponding increase in the need for professional psychology services due to increased anxiety. A study presented at this year’s American College of Allergy…
Eosinophilic esophagitis (EoE), a disorder of the esophagus, is increasingly recognized as a major cause of swallowing difficulties in children and adults. It affects about one in 2,000 people and is part of a spectrum of allergic conditions.
People have heard for years that climate change is having a significant impact on plant vegetation patterns and influencing how pollen and mold produce. A study presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual …
What keeps some immune systems youthful and effective in warding off age-related diseases? In a new paper published in Cellular & Molecular Immunology, USC Stem Cell scientist Rong Lu and her collaborators point the finger at a small subset of blood st…
If you cut your arm or undergo surgery, scarring can be a good thing; the scar tissue produced by cells called fibroblasts helps you heal. In most organs of the body, however, the accumulation of scarring (called fibrosis) is a sign of chronic disease …
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack—blocking the energy supply T cells depend on. The work, published Oct. 23 in Nature, points toward a promising new im…
Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV…
A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy—similar to that approved by the Food and Drug Administration (FDA) to treat inflammatory conditions such as arthritis—also may be an effective …
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a ‘magic bullet’ strategy that combines the precision of monoclonal antibodies with the potency of cytotoxic drugs.
